HLA Restriction of BCR-ABLb2a2Peptide-Specific T-Cell Line, P-b2
| APC Code (UPN) . | HLA A . | HLA B . | HLA C(w) . | HLA DR . | HLA DQ . | Response to b2a2 Peptide (cpm) . | Proliferation Index . |
|---|---|---|---|---|---|---|---|
| 9731999 | 2 | 7, 44 | 5, 7 | 2, 4 | 6, 7 | 5,444 ± 1,199 | 8 |
| 8959673 | 3, 31 | 35, 60 | 4, 10 | 4 | 8, 3 | 260 ± 38 | 0 |
| 6056013 | 1, 2 | 8, 60 | 7, 10 | 4, 13 | 6, 8 | 661 ± 443 | 0 |
| 2123634 | 3, 25 | 7, 39 | 7 | 2, 7 | 2, 6 | 8,255 ± 267 | 14 |
| 5024873 | 3, 11 | 7, 55 | 7, 9 | 2, 7 | 2, 6 | 5,472 ± 206 | 13 |
| 7067204 | 1, 24 | 7, 57 | 6, 7 | 2, 7 | 6, 9 | 5,571 ± 777 | 12 |
| 5021880 | 2, 24 | 18, 62 | 5, 9 | 4, 14 | 5, 8 | 261 ± 5 | 0 |
| APC Code (UPN) . | HLA A . | HLA B . | HLA C(w) . | HLA DR . | HLA DQ . | Response to b2a2 Peptide (cpm) . | Proliferation Index . |
|---|---|---|---|---|---|---|---|
| 9731999 | 2 | 7, 44 | 5, 7 | 2, 4 | 6, 7 | 5,444 ± 1,199 | 8 |
| 8959673 | 3, 31 | 35, 60 | 4, 10 | 4 | 8, 3 | 260 ± 38 | 0 |
| 6056013 | 1, 2 | 8, 60 | 7, 10 | 4, 13 | 6, 8 | 661 ± 443 | 0 |
| 2123634 | 3, 25 | 7, 39 | 7 | 2, 7 | 2, 6 | 8,255 ± 267 | 14 |
| 5024873 | 3, 11 | 7, 55 | 7, 9 | 2, 7 | 2, 6 | 5,472 ± 206 | 13 |
| 7067204 | 1, 24 | 7, 57 | 6, 7 | 2, 7 | 6, 9 | 5,571 ± 777 | 12 |
| 5021880 | 2, 24 | 18, 62 | 5, 9 | 4, 14 | 5, 8 | 261 ± 5 | 0 |
DR2 positive cells were DR15/DR51 (DRB1*1501/DRB5*0101) as defined by serology and DNA oligotyping, respectively. B2a2 peptide was used at 5 μg/mL.